20250617-中原证券-晨会聚焦_13页_761kb

报告摘要

Economic data shows moderate recovery in China, with industrial output同比增长5.8% on year, retail sales rising 6.4% compared to 5.1%, and fixed asset investment growing 3.7% (excluding farms).
National drug regulatory authorities issued an announcement optimizing approvals for innovative pharmaceutical clinical trials, aiming to support value-driven drug development.
Shanghai authorities released guidelines to promote high-quality tech insurance, supporting innovation and industry upgrades.

A-stocks exhibit steady oscillation and potential for upward movement, with policy support and liquidity concerns highlighted. Analysts forecast Fed rate cuts possibly in September and recommend tracking Middle East conflicts and policy signals.
Growth-oriented sectors like communication media and aerospace resources lead market performance, with specific recommendations for investing in areas such as cultural media and software development.
Valuations remain at median levels, making medium-term layout suitable, with increased focus on domestic demand and innovative sectors.

Battery industry: Strong performance expected from lithium-related materials with improved profitability.
Semiconductor sector: Export restrictions heighten demand for domestic chips, supporting storage and AI components.
Food and beverage: Sector maintains resilience, with recommendations on imports, domestic demand, and specific stocks.
Chemicals and other industries focus on resource attributes and cost efficiency.

Recent limit sales events include listings for companies like ST通葡 and国睿科技, with dates ranging from June 17 to 19.
Top Hong Kong Stock Connect stocks involve major players like贵州茅台, 恒生电子, and比亚迪, with varying transaction volumes and price changes.

展开完整摘要